SCHEMBL20031091

SCHEMBL20031091

CN1CC2CCC[C@H]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255097 1.00
SCHEMBL13924060 1.00
SCHEMBL13201847 1.00
SCHEMBL14589071 0.93 ALDH1A1 (0.44)
SCHEMBL26957504 0.93 ALDH1A1 (0.44)
SCHEMBL256347 0.93 ALDH1A1 (0.44)
SCHEMBL26957962 0.93 ALDH1A1 (0.44)
SCHEMBL26484979 0.91 ALDH1A1 (0.44)
SCHEMBL14407323 0.90 ALDH1A1 (0.41)
SCHEMBL21440591 0.90 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340577-A1 GCN2 INHIBITORS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2022-10-27 US disclosed
US-20210040083-A1 GCN2 INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2021-02-11 US disclosed
US-20210024521-A1 PREPARATION METHOD FOR AND INTERMEDIATE OF PYRROLO SIX-MEMBERED HETEROAROMATIC RING DERIVATIVE JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2021-01-28 US disclosed
WO-2018059314-A1 AZABICYCLE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2018-04-05 WO disclosed